Drug Shortage Report for TARO-MOMETASONE CREAM

Last updated on 2019-02-04 History
Report ID 41693
Drug Identification Number 02367157
Brand name TARO-MOMETASONE CREAM
Common or Proper name TARO MOMETASONE CREAM
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) MOMETASONE FUROATE
Strength(s) 0.1%
Dosage form(s) CREAM
Route of administration TOPICAL
Packaging size 15G
ATC code D07AC
ATC description CORTICOSTEROIDS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-12-10
Estimated end date 2019-01-18
Actual end date 2018-12-19
Shortage status Resolved
Updated date 2019-02-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v24 2019-02-04 French Compare
v23 2019-02-04 English Compare
v22 2018-12-11 French Compare
v21 2018-12-11 English Compare
v20 2018-10-18 French Compare
v19 2018-10-18 English Compare
v18 2018-10-16 French Compare
v17 2018-10-16 English Compare
v16 2018-08-03 French Compare
v15 2018-08-03 English Compare
v14 2018-06-15 French Compare
v13 2018-06-15 English Compare
v12 2018-05-25 French Compare
v11 2018-05-25 English Compare
v10 2018-04-27 French Compare
v9 2018-04-27 English Compare
v8 2018-04-13 French Compare
v7 2018-04-13 English Compare
v6 2018-03-29 French Compare
v5 2018-03-29 English Compare

Showing 1 to 20 of 24